Nestle Toll House “Break and Bake” Bar Recall Issued Over Reports of Wood Fragments in Cookie Dough

Wood fragments found in recalled Nestlé chocolate chip cookie dough bars could present an injury or choking hazard to consumers.

Two batches of Nestlé Toll House “Break and Bake” chocolate chip cookie bars are being recalled, due to a risk they may be contaminated with foreign material, following several reports of consumers finding wood fragments in the dough.

The U.S. Food and Drug Administration (FDA) announced the Nestlé Toll House “Break and Bake” bar recall on August 11, warning consumers not to use the cookie dough.

Nestlé indicates it is working closely with federal health officials on the recall, and believes the contamination was an isolated incident. The company notes that it is taking actions to address the issue, and indicates that it is not aware of any reported illnesses or injuries linked to the recalled break and bake bars.

The recall impacts two batches of Nestlé Toll House Chocolate Chip Cookie Dough “Break and Bake” bars produced on either April 24, or April 25, 2023. They were sold in 16.5 oz. packages and distributed to retailers throughout the U.S. Consumers can identify the products with batch numbers 311457531K or 311557534K, and corresponding best by dates of 8/22/23 or 10/23/23.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall does not impact any other varieties of Nestlé Toll House “Break and Bake” bars, or any varieties of their refrigerated cookie dough rolls, tubs, or edible cookie dough products.

The FDA and Nestlé warn consumers not to prepare or consume the recalled cookie dough bars, and return them to their original place of purchase to receive a full refund.

For more information on the recall, or for further assistance, consumers should contact Nestlé USA customer service by phone at (800) 681-1678 Monday-Friday from 9 a.m.-6 p.m. EST.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.